D-4F, an Apolipoprotein A-I Mimetic Peptide, Protects Human Umbilical Vein Endothelial Cells From Oxidized Low-Density Lipoprotein–induced Injury by Preventing the Downregulation of Pigment Epithelium-derived Factor Expression
- 1 June 2014
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 63 (6) , 553-561
Abstract
Aim: To investigate the protective effects of D-4F, an apolipoprotein A-I mimetic peptide, on oxidized low-density lipoprotein (ox-LDL)–induced injury of vascular endothelial cells and the potential role of pigment epithelium–derived factor (PEDF). Methods: Cytotoxicity was assessed by the apoptotic rate, 3-(4,5-dimethylthiazol-2-y-l)-2,5-diphenyl-2H-tetrazolium bromide assay, and lactate dehydrogenase release. PEDF levels were analyzed with Western blot and quantitative real-time polymerase chain reaction. Redox status was measured by the levels of the reactive oxygen species, malondialdehyde, superoxide dismutase, and nitric oxide. Results: Ox-LDL reduced cell viability and induced apoptosis and LDH release from human umbilical vein endothelial cells, but the cytotoxic effects of ox-LDL were significantly inhibited by pretreatment with D-4F. Additionally, D-4F could scavenge intracellular reactive oxygen species, suppress the production of lipid peroxides, and improve endogenous antioxidant activity. Ox-LDL decreased PEDF expression in human umbilical vein endothelial cells in a concentration-dependent manner, and this decrease was markedly attenuated by D-4F. However, silencing PEDF by short interfering RNA blocked the inhibitory effects of D-4F on ox-LDL–induced oxidative stress and cellular injury. Conclusions: D-4F effectively protects vascular endothelial cells against ox-LDL–induced injury by preventing the downregulation of PEDF expression.Keywords
This publication has 30 references indexed in Scilit:
- Oxidized Low-Density Lipoprotein and Atherosclerosis Implications in Antioxidant TherapyThe American Journal of the Medical Sciences, 2011
- Apolipoprotein A-I Mimetic PeptidesCardiology in Review, 2010
- D-4F, an Apolipoprotein A-I Mimetic Peptide, Promotes Cholesterol Efflux from Macrophages via ATP-Binding Cassette Transporter A1The Tohoku Journal of Experimental Medicine, 2010
- Apoprotein A-I mimetic peptides and their potential anti-atherogenic mechanisms of actionCurrent Opinion in Lipidology, 2009
- Apolipoprotein A-I mimetic peptidesCurrent Atherosclerosis Reports, 2008
- Agents that block advanced glycation end product (AGE)-RAGE (receptor for AGEs)-oxidative stress system: a novel therapeutic strategy for diabetic vascular complicationsExpert Opinion on Investigational Drugs, 2008
- Proatherogenic high-density lipoprotein, vascular inflammation, and mimetic peptidesCurrent Atherosclerosis Reports, 2008
- An apolipoprotein A-I mimetic dose-dependently increases the formation of preβ1 HDL in human plasmaJournal of Lipid Research, 2008
- Role of Oxidative Stress in the Development of Vascular Injury and its Therapeutic Intervention by NifedipineCurrent Medicinal Chemistry, 2008
- Oral D-4F Causes Formation of Pre-β High-Density Lipoprotein and Improves High-Density Lipoprotein–Mediated Cholesterol Efflux and Reverse Cholesterol Transport From Macrophages in Apolipoprotein E–Null MiceCirculation, 2004